This is another severe illness caused by a virus found in ticks, mainly in Africa and the Middle East. People can get it through tick bites or contact with infected animal blood. Symptoms include high fever, bleeding, and it can be fatal.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Crimean-Congo hemorrhagic fever (CCHF) is a viral infection spread mainly by ticks. It belongs to the viral hemorrhagic fevers, a group of illnesses that damage blood vessels and can affect many organs at once. When CCHF becomes severe, the blood's ability to clot breaks down, which can lead to bleeding, organ failure and shock. Most people infected with the virus have no symptoms or only a mild feverish illness, and children usually have milder disease. The concern is the smaller group who become seriously ill: among people sick enough to be hospitalized, about 30% die, usually in the second week. The disease is found in parts of Africa, the Balkans, the Middle East and Asia, and cases have also occurred in Turkey, Russia and Spain.
The virus lives in a cycle between ticks, mainly a type called Hyalomma, and the animals they feed on, such as cattle, sheep and goats. The animals carry the virus in their blood for a week or two without looking sick. People become infected through a tick bite or through contact with infected animal blood or tissue during or just after slaughter. That is why farmers, slaughterhouse workers, veterinarians, herders and people who slaughter animals at home are most often affected, along with hunters and people spending time outdoors where these ticks are common. The virus can also pass from person to person through close contact with an infected person's blood or body fluids. Family caregivers and health workers are at risk, and outbreaks have occurred in hospitals when equipment was not properly sterilized or needles were reused. There is no widely available vaccine, so prevention depends on reducing exposure: covering skin and using tick repellent where ticks are common, checking for and removing ticks promptly, wearing gloves when handling animals or raw meat in affected areas, and using gloves and protective equipment when caring for someone who is ill.
Early CCHF looks like many other infections, so the most important clue is a person's recent history: a tick bite, contact with livestock blood, care of a sick person, or travel to an area where the virus circulates. Symptoms usually begin within one to three days of a tick bite and five to six days after contact with infected blood, although the full range runs to about two weeks. The diagnosis is confirmed with blood tests. In the first week of illness, the main test is RT-PCR (reverse transcription polymerase chain reaction), which detects the virus's genetic material. Antibody tests become useful after about the fifth day, but people who are very ill may not produce measurable antibodies, so doctors often combine both kinds of test. Routine blood work commonly shows low platelets (the cells that help blood clot), signs of liver inflammation and slowed clotting, and these results help gauge how severe the illness is. Because the samples are hazardous, they are handled by specialized laboratories, and the person is cared for with strict infection control while results are pending.
There is currently no specifically approved treatment for CCHF. The care that matters most is early, intensive supportive treatment in a hospital: careful management of fluids and body salts, close monitoring of blood clotting and organ function, and treatment of complications as they appear. This can include transfusions of blood products to address bleeding and support for failing organs. Starting this care early improves the chance of survival. Ribavirin, a broad-spectrum antiviral medicine, is sometimes given, especially early in the illness or after a high-risk exposure such as a needle-stick injury. However, a careful review of the evidence could not determine whether it reduces deaths, because the studies that appear to favor it were not designed to separate its effect from that of good early care. The World Health Organization recommends that, where possible, people treated with ribavirin be enrolled in clinical trials. Other antivirals are being studied but are not established treatments. People with CCHF are cared for with barrier nursing, meaning staff use gloves, gowns, eye protection and masks, to protect caregivers and other patients.
Illness typically starts suddenly with fever, muscle aches, dizziness, headache, neck pain, sore eyes and sensitivity to light, often with nausea, vomiting, diarrhea or abdominal pain. Some people become confused or have sharp mood changes, followed after a few days by drowsiness and exhaustion. In severe cases, bleeding signs appear after several days, ranging from a rash of tiny red or purple spots and bruising to bleeding from the gums, nose or other sites, and the liver, kidneys or lungs can begin to fail after about the fifth day. For people who recover, improvement usually begins around 9 to 10 days after symptoms start, and many leave the hospital then, although recovery can take longer for some. Pregnancy carries a particularly high risk for both the pregnant person and the baby, so pregnant people with possible exposure need especially close attention. Because close contacts can be infected, public health teams usually follow people who were exposed, asking them to watch for symptoms for 14 days after their last contact.
If you develop a fever or flu-like illness within 14 days of a tick bite, handling animal blood or raw meat, caring for someone with CCHF, or traveling to an area where it occurs, get medical care the same day and tell the staff about the exposure right away so they can test and protect others. Seek emergency care immediately for bleeding from the gums, nose or elsewhere, a spreading rash of tiny red or purple spots or unexplained bruising, or new confusion or extreme drowsiness in someone with a possible exposure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Crimean-Congo Hemorrhagic Fever is like, what's helped you, or ask the community a question.